SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-21-009663
Filing Date
2021-04-23
Accepted
2021-04-23 09:31:11
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A acrx20210416_defa14a.htm DEFA14A 16884
2 a01.jpg GRAPHIC 115087
3 a02.jpg GRAPHIC 88480
  Complete submission text file 0001437749-21-009663.txt   298053
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35068 | Film No.: 21846973
SIC: 2834 Pharmaceutical Preparations